U.S. Capital Markets Stock News

NYSE:KD
NYSE:KDIT

Kyndryl Broadridge Deal Highlights AI Security And Valuation Opportunity

Kyndryl Holdings (NYSE:KD) has expanded its collaboration with Broadridge Financial Solutions. The partnership focuses on modernizing and securing core financial platforms with AI-enabled and quantum-safe capabilities. Kyndryl will apply its Kyndryl Bridge and Agentic AI Framework to Broadridge’s critical financial infrastructure. This new agreement puts Kyndryl directly in the middle of core technology upgrades for a large, highly regulated financial services operator. For investors...
NYSE:DELL
NYSE:DELLTech

A Look At Dell Technologies (DELL) Valuation After Blockbuster AI Earnings And US$9.7b Pentagon Deal

Dell Technologies (DELL) just delivered a blockbuster quarter, issuing higher full-year revenue and AI server guidance alongside a new US$9.7b Pentagon software contract. This combination sent the stock sharply higher and refocused attention on AI infrastructure. See our latest analysis for Dell Technologies. Those earnings and contract headlines come on top of an already sharp move in the stock, with a 1-day share price return of 32.76% and a 30-day share price return of 100.27% helping push...
NYSE:JPM
NYSE:JPMBanks

A Look At JPMorgan Chase (JPM) Valuation As Higher Cost Guidance Follows Strong Trading And Investment Banking Outlook

JPMorgan Chase (JPM) recently told investors to expect annual costs of about US$106b instead of US$105b, with CEO Jamie Dimon linking the revised figure to stronger trading and investment banking activity. See our latest analysis for JPMorgan Chase. After the cost guidance update, JPMorgan Chase's 1-day share price return of 0.87% comes against a year to date share price return that is down 8.04%. The 1-year total shareholder return of 15.58% and 3-year total shareholder return of 128.15%...
NYSE:LOW
NYSE:LOWSpecialty Retail

Will Lowe's (LOW) Dividend Hike and Aristocrat Focus Reframe Its Capital Return Narrative?

Lowe's Companies' board recently approved a quarterly cash dividend of US$1.25 per share, payable on August 5, 2026, to shareholders of record on July 22, 2026, marking a 4% increase from the prior US$1.20 payout and extending a quarterly dividend record that dates back to its 1961 listing. This latest increase underscores Lowe's decades-long pattern of consistent dividend growth and its commitment to maintaining Dividend Aristocrat status as part of how it returns cash to...
NYSE:MMS
NYSE:MMSProfessional Services

Maximus Expands Term B Loans To Fund Buybacks And Reshape Balance Sheet

Maximus (NYSE:MMS) amended its credit agreement to add $325 million to its existing term B loans. The company plans to use the new debt for share repurchases, working capital, and repayment of existing debt. Maximus, trading at $61.93, is taking on additional term B loan financing that directly affects how it allocates capital between shareholders and creditors. The move comes after the stock declined 28.4% year to date and 13.1% over the past year, with a 22.0% decline over three years and...
NasdaqGS:AAL
NasdaqGS:AALAirlines

Is American Airlines Group (AAL) Pricing Look Attractive After Recent Share Price Rebound

Wondering whether American Airlines Group at US$14.64 is a bargain or a value trap? This article walks through the key facts so you can judge the stock's price tag with more confidence. The stock has returned 5.7% over the last 7 days and 23.6% over the last 30 days. Year to date it is down 5.4%. The 5 year return shows a decline of 39.8%, with a 28.3% return over the last year and a 1.5% decline over 3 years. Recent coverage of American Airlines Group has focused on ongoing industry wide...
NYSE:ICE
NYSE:ICECapital Markets

Is ICE’s Record Energy OI and GPU Futures Push Altering The Investment Case For Intercontinental Exchange (ICE)?

In May 2026, Intercontinental Exchange, Inc. reported record open interest and liquidity across its global natural gas and power markets, alongside regulatory approvals for ICE ETF Hub expansion in Europe and Australia and plans to introduce GPU compute futures with Ornn, further broadening its trading and data infrastructure footprint. These developments highlight how ICE is deepening its role in critical energy hedging and emerging GPU compute benchmarks while extending ETF primary market...
NasdaqGS:DXCM
NasdaqGS:DXCMMedical Equipment

How Investors May Respond To DexCom (DXCM) Global App Recalls Over Delayed Glucose Alerts

In April 2026, Dexcom voluntarily initiated Class II global recalls of its G7, ONE and ONE+ iOS and watchOS CGM apps after an FDA enforcement report highlighted a software defect that could delay real-time glucose readings and alerts, increasing the risk of users relying on outdated data to manage hypoglycemia or hyperglycemia. This recall underscores how even a low-level software issue in widely distributed digital health tools can quickly become a material patient-safety and...
NYSE:STE
NYSE:STEMedical Equipment

Is It Time To Reconsider STERIS (STE) After Recent Share Price Weakness?

If you are wondering whether STERIS at around US$212 a share offers good value or if you are better off waiting on the sidelines, this article walks through what the current price might be implying. The stock has been weak recently, with the share price down about 1.8% over the last week, 0.8% over the last month, 14.9% year to date and 12.4% over the past year. These moves may change how you view its risk and reward trade off. Recent coverage around STERIS has focused on its role within...
NasdaqGM:FUTU
NasdaqGM:FUTUCapital Markets

Why Futu Holdings (FUTU) Is Up 15.9% After Booking a Major Regulatory Penalty and Profit Drop

In the past week, Futu Holdings reported Q1 2026 results showing revenue rising to HK$5,855.99 million while net income fell to HK$850.55 million after fully reflecting a proposed RMB1.85 billion regulatory penalty from Chinese authorities over alleged unlicensed activities in mainland China. Despite the earnings impact of the proposed China Securities Regulatory Commission fine, Futu’s funded accounts grew 34% year over year to 3.59 million, with mainland China now representing about 13% of...
NasdaqGS:WDC
NasdaqGS:WDCTech

Western Digital’s Post Quantum Drives Put AI Storage Story In Focus

Western Digital (NasdaqGS:WDC) has introduced high-capacity hard drives that integrate post-quantum cryptography to secure AI-era data infrastructure. The new drives apply NIST-approved, quantum-resilient security standards directly in storage hardware to address long-term data protection risks. The launch targets enterprise and cloud environments where AI workloads generate sensitive, long-lived data sets. Western Digital is bringing this step into the spotlight at a time when its stock...
NasdaqGS:DYN
NasdaqGS:DYNBiotechs

Dyne Therapeutics (DYN) Is Up 11.3% After FDA BLA Filing For DMD Drug Candidate Zeleciment Rostudirsen

Dyne Therapeutics has submitted a Biologics License Application to the FDA for zeleciment rostudirsen (DYNE-251) seeking Accelerated and Priority Review to treat Duchenne muscular dystrophy patients amenable to exon 51 skipping, based on Phase 1/2 DELIVER data showing increased dystrophin production, functional gains and a favorable safety profile. This filing, together with the ongoing Phase 3 FORZETTO confirmatory trial and a broader exon-skipping pipeline, positions Dyne as a potential...
NYSE:AXP
NYSE:AXPConsumer Finance

Is It Time To Reassess American Express (AXP) After Recent Share Price Swings?

Wondering if American Express at around US$316 per share is giving you fair value for the risk you are taking, or if the current price is out of line with what you are actually getting. The stock has gained 1.5% over the past week, softened around 1.0% over the last month, is down 15.1% year to date, yet shows an 8.8% return over the past year and has more than doubled over 5 years. Recent headlines have focused on American Express as a major player in payments and card services. This often...
NYSE:KMI
NYSE:KMIOil and Gas

Has Kinder Morgan (KMI) Share Price Weakness Opened A Potential Opportunity For Investors?

If you are wondering whether Kinder Morgan's share price still offers value at around US$31.08, it helps to first line up what the current valuation is actually telling you. The stock is up 12.2% year to date and 15.4% over the past year, even though it has fallen 8.0% over the last week and 4.5% over the past month. This can change how the market is weighing its risks and rewards. Recent headlines have highlighted Kinder Morgan's role as a major energy infrastructure provider in the US,...
NYSE:VICI
NYSE:VICISpecialized REITs

Is VICI Properties (VICI) Offering Value After Trailing Specialized REIT Peers This Year?

Wondering if VICI Properties at US$28.22 is a bargain or a trap? This article walks through what the current price might be implying about the stock's value. The share price is roughly flat year to date with a 0.2% gain, but has declined 1% over the last week and 1.3% over the past month, while the return over the last year is down 5.5%. Recent headlines around VICI Properties have focused on how the stock has trailed the broader Specialized REITs peer group over the last year, reinforcing...
NYSE:HL
NYSE:HLMetals and Mining

Is It Too Late To Consider Hecla Mining (HL) After Its Strong Multi Year Run?

Investors may be wondering whether Hecla Mining, at a last close of US$17.77, still offers value after its recent run, or if most of the opportunity is already priced in. The stock has delivered a 4.7% gain over the last 7 days, is down 1.6% over the last 30 days and 5.8% year to date, while its 1 year and 3 year returns sit at 246.1% and 228.4% respectively, and its 5 year return is 103.8%. These moves have been accompanied by continued investor attention on Hecla Mining, including coverage...
NYSEAM:HYLN
NYSEAM:HYLNElectrical

Hyliion (HYLN) Rises After KARNO Generator Chosen For US Navy Unmanned Vessel Trials

In May 2026, Hyliion Holdings Corp. announced that the U.S. Navy’s Office of Naval Research, in partnership with DARPA, selected the unmanned USX-1 Defiant as a candidate test vessel for four 200 KW keel‑cooled KARNO Cores, forming an 800 KW drop‑in onboard power system for sea trials. This defense‑focused deployment positions Hyliion’s modular, low‑maintenance KARNO generator as a potential fit for long‑duration autonomous naval operations requiring distributed, redundant shipboard...
NasdaqGM:RZLV
NasdaqGM:RZLVSoftware

Why Rezolve AI (RZLV) Is Up 13.3% After Powering Live Enhanced's Telehealth Concierge Platform

In May 2026, Enhanced Group Inc. announced a broad partnership with Rezolve AI to power Live Enhanced, its direct-to-consumer digital telehealth platform, using Rezolve’s AI technology for medical concierge functions and data-driven personalization. This collaboration positions Rezolve AI’s software as core infrastructure in an emerging consumer health service, potentially extending its reach beyond retail-focused commerce applications into digital care experiences. Next, we’ll explore how...
NasdaqCM:HTLM
NasdaqCM:HTLMSpecialty Retail

HomesToLife (HTLM) Trailing 4.5% Net Margin Supports Bullish Profitability Narratives

HomesToLife (HTLM) has opened 2026 with Q1 revenue of US$92.5 million and basic EPS of US$0.04. Trailing twelve month revenue sits at US$390.9 million and EPS at US$0.19, framing a business that is currently earning at a higher run rate than any single recent quarter. The company has seen revenue move from US$335.1 million and EPS of US$0.09 on a trailing basis in Q4 2024 to US$390.9 million and EPS of US$0.19 by Q1 2026. This has occurred alongside a trailing net profit margin of 4.5% and...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

WHO Ebola Trial Puts Regeneron’s Maftivimab Platform In Investor Focus

World Health Organization recommends Regeneron’s maftivimab for priority evaluation in clinical trials for the current Bundibugyo ebolavirus outbreak. Maftivimab is a component of Inmazeb, which is already approved for Zaire ebolavirus treatment. The recommendation positions Regeneron Pharmaceuticals (NasdaqGS:REGN) within an active emergency response affecting multiple African countries. Regeneron Pharmaceuticals, traded as NasdaqGS:REGN, is widely known for its antibody platforms and...
NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

Assessing Palantir Technologies (PLTR) Valuation After Strong Multi‑Year Share Price Momentum

Key business snapshot for Palantir Technologies (PLTR) Palantir Technologies (PLTR) develops software platforms used by government and commercial clients, with revenue of about US$5.2b and net income of roughly US$2.3b across its Gotham, Foundry, Apollo, and AI products. See our latest analysis for Palantir Technologies. Palantir’s share price has moved sharply in the short term, with a 1-day share price return of 9.21% and a 7-day return of 14.36%. Its year-to-date share price return has...
NasdaqGS:UFCS
NasdaqGS:UFCSInsurance

Assessing United Fire Group (UFCS) Valuation After Strong Recent Shareholder Returns

United Fire Group (UFCS) is on investor watch after recent share price moves, with the stock down about 6% over the past week but up roughly 11% over the past month. See our latest analysis for United Fire Group. Zooming out from the latest pullback, United Fire Group’s share price has a 24.6% year to date gain and the 1 year total shareholder return of 59.1% points to strong recent momentum despite short term swings. If the insurance sector’s recent moves have your attention, this can be a...
NYSE:INFQ
NYSE:INFQTech

A Look At Infleqtion (INFQ) Valuation After Oxford Quantum Innovation Centre Expansion

Infleqtion (INFQ) is back in focus after announcing a new Quantum Innovation Centre in Oxford, a UK hub that will triple its research, production, and systems integration capacity for quantum technologies. See our latest analysis for Infleqtion. The stock has pulled back in the last session, with a 1-day share price return of down 8.7% to US$16.22. Recent momentum remains strong given the 30-day and 90-day share price returns of 30.7% and 36.1% respectively, even though the year-to-date share...
NYSE:FDS
NYSE:FDSCapital Markets

A Look At FactSet Research Systems (FDS) Valuation After Optimistic Analyst Expectations For Upcoming Quarterly Results

Recent analyst commentary around FactSet Research Systems (FDS) has focused on expectations for its upcoming quarterly results, with attention on demand trends, international pricing, managed services, and recent changes to the sales compensation model. See our latest analysis for FactSet Research Systems. The recent 1 day share price return of 2.75% and 7 day return of 5.81% suggest short term momentum is improving. However, the year to date share price return has fallen 13.84% and the 1...